Ferring
| Ferring Holding SA
|
|
|---|---|
 |
|
| legal form | Corporation |
| founding | 1950 |
| Seat |
Saint-Prex Switzerland
|
| management | Frederik Paulsen jun. ( Chairman of the Board of Directors ) |
| Number of employees | 5,000 (2016) |
| sales | 1.5 billion CHF (2015) |
| Branch | pharmacy |
| Website | www.ferring.com |
The Ferring Holding SA , based in Saint-Prex and roots in Sweden is an internationally active Swiss pharmaceutical company , the drug developed and marketed. It mainly focuses on the research and manufacture of pharmaceuticals based on peptides .
The company employs around 5,000 people worldwide, 650 of them in Switzerland, and generated sales of CHF 1.5 billion in 2015 . Ferring sells its products in 60 countries worldwide. The company is located through Dr. Frederik Paulsen Foundation is entirely privately owned and is run by Frederik Paulsen's son Frederik Paulsen jun. guided.
history
The company was founded in 1950 under the name Nordiska Hormon Laboratoriet by the German-born Frederik Paulsen in Malmö , Sweden, and renamed Ferring in 1954 . The company name is derived from the North Sea island of Föhr , where Paulsen's parents come from.
With the commercial synthesis of hormones , the production of ACTH and other pituitary hormones , Ferring was one of the pioneers in this pharmaceutical field in the 1950s and 1960s. In 1961 Paulsen also acquired his mother's parent company in Alkersum on Föhr. A decisive step was the development of the active ingredient desmopressin , which is still used today under the trade name Minirin for diabetes insipidus and enuresis (bed wetting).
Research and development currently focuses on therapy with synthetic peptides, including galenics and the manufacture of drugs. On this basis, Ferring has now specialized in the therapeutic areas of fertility , urology , gastroenterology , endocrinology and obstetrics .
Products
Ferring sells the following drugs (active ingredient in brackets):
- Bravelle ( Urofollitropin ) - Used to treat female infertility
- Cortiment ( budesonide ) - Used to treat ulcerative colitis
- Firmagon ( Degarelix ) - Used to treat prostate cancer
- Menogon ( Menotropin ) - Used to treat female infertility
- Minirin ( Desmopressin ) - Used to treat enuresis and diabetes insipidus
- Pabal ( Carbetocin ) - prevention of uterine atonia after caesarean section delivery
- Pentasa ( mesalazine ) - Used to treat inflammatory bowel disease ( IBD )
- Tractocile ( Atosiban ) - to suppress labor ( tocolysis )
- Zomacton ( Somatropin ) - Used to treat stunted growth
Ferring in Germany
Ferring Arzneimittel GmbH was one of the first subsidiaries to be founded in Germany in 1956, 6 years after the parent company. The company headquarters were relocated from Düsseldorf to Kiel in 1973 . A total of around 325 employees currently work here.
Ferring Foundation
The Ferring Foundation was established by Frederik Paulsen in 1988. The purpose of the foundation is to maintain and promote the Frisian language ( Fering ) and culture as well as to research the living conditions on Föhr and the region.
literature
- Birgit Ammon: Ahead of its time. Dr. Friedrich Paulsen 1909 - 1997, the man who founded Ferring. Ferring GmbH, Kiel 1999. Online here
- Tobias Birken, Matthias Georgi, Katharina Roth: Frederik Paulsen: A Frisian life. August Dreesbach Verlag , Munich 2019.
- Camilla Olga Katharina Freiin von Nordenflych: The importance of Dr. med. Frederik Paulsen as an entrepreneur, Föhhringer global citizen and researcher with regard to the therapy of endocrine disorders. Dissertation, Department of Medicine, University of Hamburg, 2006. Posted online by the University of Hamburg.
- Jörn Radke: The roots on Föhr and the world as a market , Kieler Nachrichten , December 29, 2006, No. 303, p. 21.
- Axel Schnorbus: Ferring strong in research in Kiel , FAZ , June 22, 1995, No. 142, p. 18.
Web links
- Ferring international website
- Website of the German subsidiary Ferring Arzneimittel GmbH
- Homepage of the Ferring Foundation
Individual evidence
- ↑ Entry of Ferring Holding SA in the commercial register of the Canton of Vaud ( page can no longer be accessed , search in web archives ) Info: The link was automatically marked as defective. Please check the link according to the instructions and then remove this notice.
- ↑ a b c Tages-Anzeiger : Billionaire turns Switzerland into a polar researcher nation , accessed on May 3, 2016
- ^ Andreas Mettenleiter : Personal reports, memories, diaries and letters from German-speaking doctors. Supplements and supplements III (I – Z). In: Würzburg medical history reports. Volume 22, 2003, pp. 269-305, here: pp. 283 f.
